← Back to Search

VAX-MOM Intervention for Increasing Vaccination During Pregnancy

N/A
Waitlist Available
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients: Sex is female
Patients
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months during the 2019-2020 flu season (baseline), compared to 6 months during the 2021-2022 flu season (intervention)
Awards & highlights

Study Summary

This trial will test whether giving obstetricians' offices feedback on their influenza and pertussis vaccination rates will increase the rates.

Who is the study for?
This trial is for pregnant women who are eligible to receive the influenza or Tdap vaccine. It includes any provider, nurse, or staff associated with participating sites. There are no exclusion criteria for patients or providers in this study.Check my eligibility
What is being tested?
The VAX-MOM Intervention is being tested against the standard of care to see if it can increase vaccination rates among pregnant women and reduce complications from flu and pertussis infections.See study design
What are the potential side effects?
Typical side effects of vaccines like influenza and Tdap may include soreness at injection site, mild fever, fatigue, headache, muscle pain. Serious side effects are rare but can include allergic reactions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am female.
Select...
It seems like your message was cut off. Could you please provide more details or context so that I can assist you effectively?
Select...
I am female.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months during the 2019-2020 flu season (baseline), compared to 6 months during the 2021-2022 flu season (intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months during the 2019-2020 flu season (baseline), compared to 6 months during the 2021-2022 flu season (intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in the rate of Tdap vaccination
Change in the rate of influenza vaccination
Secondary outcome measures
Flu and Tdap vaccination rates by insurance group (public vs private)
Number of patients seen in the practices
Number of providers/nurses/staff completing training modules

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: VAX-MOM InterventionExperimental Treatment1 Intervention
Group II: Standard of CareActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor
837 Previous Clinical Trials
508,214 Total Patients Enrolled
Centers for Disease Control and PreventionFED
875 Previous Clinical Trials
22,467,499 Total Patients Enrolled
University of California, Los AngelesOTHER
1,529 Previous Clinical Trials
10,267,899 Total Patients Enrolled

Media Library

Standard of Care Clinical Trial Eligibility Overview. Trial Name: NCT04444518 — N/A
Pregnancy Research Study Groups: VAX-MOM Intervention, Standard of Care
Pregnancy Clinical Trial 2023: Standard of Care Highlights & Side Effects. Trial Name: NCT04444518 — N/A
Standard of Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT04444518 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still spots available for participants in this clinical trial?

"As per clinicaltrials.gov, this medical trial is no longer actively seeking participants; the notice was initially published on November 11th 2020 and last updated on August 9th 2022. Nonetheless, at present moment 250 other trials require patients to join their study."

Answered by AI

In what locations can participants access this research?

"At the moment, individuals may sign up for this medical trial at 37 sites. Locations span from Westlake Village and Penn Yan to Los Angeles and other towns. In order to minimize any travel burden, it is suggested that participants select a clinic situated close by them."

Answered by AI

Who else is applying?

What site did they apply to?
Hubert Humphrey Comprehensive Health Center
MLK Outpatient Center
Ronald Reagan OB
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
0
What state do they live in?
California
Recent research and studies
clinicaltrials.govStudy
Increasing Influenza and Tdap Vaccination of Pregnant Women
Cynthia Rand 2020. "Increasing Influenza and Tdap Vaccination of Pregnant Women". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04444518.
All > Influenza
~461 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top